Lv3
300 积分 2023-07-26 加入
Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review
15天前
已完结
Medication-Related Osteonecrosis of the Jaw
24天前
已完结
Dalpiciclib plus endocrine therapy in women with HR+/HER2− advanced breast cancer and visceral crisis: a multicenter, nonrandomized, phase 2 DARVIN trial
28天前
已完结
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer
30天前
已完结
Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial
30天前
已完结
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma: clinical activity and safety results from AliCe, a single-arm multicentre phase II DeCOG trial
1个月前
已完结
Osteonecrosis of the maxilla and mandible related to trastuzumab, docetaxel and carboplatin
1个月前
已关闭
Overall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer
2个月前
已完结
Multisection CT Protocols: Sex- and Age-specific Conversion Factors Used to Determine Effective Dose from Dose-Length Product
3个月前
已完结
Synergistic Combinations for Improved Therapeutic Outcomes in Triple Negative Breast Cancer
4个月前
已完结
皖公网安备34019202002308
